April 2010
Volume 51, Issue 13
ARVO Annual Meeting Abstract  |   April 2010
AlphaCor Keratoprosthesis for the Managment of High-Risk Keratoplasty Patients
Author Affiliations & Notes
  • M. Rauen
    Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa
  • J. E. Sutphin
    Dept of Ophthalmology, Univ of Kansas Medical Center, Prairie Village, Kansas
  • K. M. Goins
    Ophthal/Vis Sci, Univ of Iowa Hospitals & Clinics, Iowa City, Iowa
  • Footnotes
    Commercial Relationships  M. Rauen, None; J.E. Sutphin, None; K.M. Goins, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 1151. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Rauen, J. E. Sutphin, K. M. Goins; AlphaCor Keratoprosthesis for the Managment of High-Risk Keratoplasty Patients. Invest. Ophthalmol. Vis. Sci. 2010;51(13):1151.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Prosthetic corneas offer an alternative to donor tissue for patients at high risk for graft failure. The AlphaCor Keratoprosthesis is one such device and its composition offers biointegration into the host cornea. The purpose of this study is to describe the clinical outcomes of eight patients who underwent AlphaCor device implantation at a single center.

Methods: : Between 8/30/04 and 5/15/08, eight AlphaCor devices were placed in patients considered to be high risk keratoplasty candidates. The mean age at the time of surgery was 60 years (range 27-80 years). The mean number of keratoplasties per patient prior to AlphaCor placement was 3.25 per patient. Preoperative best corrected visual acuity (BCVA) ranged from HM at 3 feet to 20/250. Three of eight patients (37.5%) had Type I surgery using a limbal pocket incision with a Gundersen conjunctival flap. Three of eight patients (37.5%) had Type II surgery using a temporal clear cornea pocket incision. Two of eight patients (25%) had Type III surgery using a keratoplasty wound pocket incision.

Results: : Six of eight patients (75%) have active device retention. In six active patients, two patients have BCVA of 20/40 or better whereas four have vision of 20/200 or worse (range 20/20 to CF at 1 foot). Pre-existing end stage glaucomatous optic neuropathy is the reason for poor vision in three of the four poorest seeing eyes. Stromal melting occurred in three patients despite use of Medroxyprogesterone topically. Of these, two were successfully treated with a lamellar onlay keratoplasty. Retroprosthetic membrane formation occurred in four of eight patients (50%). Two of these occurred in patients with Type I surgery and two occurred in patients with Type II surgery. No retroprosthetic membranes occurred with Type III surgery.

Conclusions: : The device retention rate in this study is superior to that in the reported literature. Type III surgery may lead to less retroprosthetic membrane formation. Performance of Stage II surgery followed by use of a piggyback contact lens fitting system is required for best visual performance in eyes with excellent visual potential.

Keywords: cornea: clinical science • transplantation 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.